Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7,227,333
-
Total 13F shares
-
57,438,478
-
Share change
-
-84,239
-
Total reported value
-
$404,373,495
-
Put/Call ratio
-
0.49%
-
Price per share
-
$7.04
-
Number of holders
-
123
-
Value change
-
-$10,789,742
-
Number of buys
-
64
-
Number of sells
-
57
Institutional Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q4 2022
As of 31 Dec 2022,
Kezar Life Sciences Inc - COMMON-STOCK (KZR) was held by
123 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,438,478 shares.
The largest 10 holders included
Avidity Partners Management LP, ORBIMED ADVISORS LLC, STATE STREET CORP, BlackRock Inc., SUVRETTA CAPITAL MANAGEMENT, LLC, Bellevue Group AG, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, CHI Advisors LLC, and Prosight Management, LP.
This page lists
123
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.